Cure Genetics Competitors and Similar CompaniesClear all
Cure Genetics's competitors and similar companies include Zyngenia, Reglagene, Cytura Therapeutics and Exicure.
 Cure Genetics Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases. |  Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways. |  Reglagene Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment. |  Cytura Therapeutics Cytura Therapeutics is a pharmaceutical company aiming to find a solution to stop the destabilization of the genome. |  Exicure Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets. | |
Founding Date | Founding Date 2016 | Founding Date 2009 | Founding Date 2016 | Founding Date 2018 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Washington, US HQ | Locations Tucson, US HQ | Locations Oss, NL HQ | Locations Skokie, US HQ Chicago, US |
Employees | Employees 15 | Employees N/A | Employees 14 | Employees 1 | Employees 29 |
Funding | |||||
Latest funding round | Latest funding round $ 9.5m (about 6 years ago) | Latest funding round $ 25m (over 15 years ago) | Latest funding round $ 546.4k (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 26.5m | Total funding raised $ 25m | Total funding raised $ 546.4k | Total funding raised N/A | Total funding raised $ 94m |
For sources of this data, please see the company profile
View Company Profiles
Zyngenia
HQ
Washington, US
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
View companyReglagene
HQ
Tucson, US
Employees
14
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
View companyCytura Therapeutics
HQ
Oss, NL
Employees
1
Cytura Therapeutics is a pharmaceutical company aiming to find a solution to stop the destabilization of the genome.
View companyExicure
HQ
Skokie, US
Employees
29
Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
View company